Nanoform Finland Plc (NANOFH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nanoform Finland Plc (NANOFH) has a cash flow conversion efficiency ratio of -0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.38 Million ≈ $-3.95 Million USD) by net assets (€44.58 Million ≈ $52.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View Nanoform Finland Plc (NANOFH) share price today for real-time trading data and today's change.
Nanoform Finland Plc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Nanoform Finland Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see how much is Nanoform Finland Plc worth for the company's overall valuation and market capitalisation.
Nanoform Finland Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanoform Finland Plc ranked by their cash flow conversion efficiency. Also see NANOFH asset base for a full breakdown of the balance sheet.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guizhou Zhongyida Co Ltd
SHG:900906
|
0.195x |
|
Comscore Inc
NASDAQ:SCOR
|
-0.025x |
|
Hennessy Ad
NASDAQ:HNNA
|
0.023x |
|
Asia Pacific Satellite Inc
KQ:211270
|
0.011x |
|
Hai Kwang Enterprise Corp
TW:2038
|
0.183x |
|
Flexible Solutions International Inc
NYSE MKT:FSI
|
-0.069x |
|
FELIX Gold Ltd
AU:FXG
|
-0.022x |
|
Wooree E&L Co. Ltd
KQ:153490
|
-0.031x |
Annual Cash Flow Conversion Efficiency for Nanoform Finland Plc (2017–2024)
The table below shows the annual cash flow conversion efficiency of Nanoform Finland Plc from 2017 to 2024. Review how financially flexible is Nanoform Finland Plc to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €60.03 Million ≈ $70.18 Million |
€-18.28 Million ≈ $-21.37 Million |
-0.304x | -13.22% |
| 2023-12-31 | €66.95 Million ≈ $78.27 Million |
€-18.00 Million ≈ $-21.05 Million |
-0.269x | -16.79% |
| 2022-12-31 | €87.21 Million ≈ $101.96 Million |
€-20.08 Million ≈ $-23.48 Million |
-0.230x | -35.58% |
| 2021-12-31 | €84.49 Million ≈ $98.78 Million |
€-14.35 Million ≈ $-16.78 Million |
-0.170x | +24.86% |
| 2020-12-31 | €62.64 Million ≈ $73.23 Million |
€-14.16 Million ≈ $-16.55 Million |
-0.226x | +69.08% |
| 2019-12-31 | €7.93 Million ≈ $9.27 Million |
€-5.80 Million ≈ $-6.78 Million |
-0.731x | -144.64% |
| 2018-12-31 | €5.03 Million ≈ $5.88 Million |
€-1.50 Million ≈ $-1.76 Million |
-0.299x | -111.03% |
| 2017-12-31 | €-246.96K ≈ $-288.72K |
€-669.18K ≈ $-782.34K |
2.710x | -- |
About Nanoform Finland Plc
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) na… Read more